文献速递结核与非结核分枝杆菌艾滋病与性传播感染

HIV未感染儿童肺结核治疗决策算法的开发

Development of a Treatment-decision Algorithm for Human Immunodeficiency Virus-uninfected Children Evaluated for Pulmonary Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2021-01-01

最终模型AUC为0.87,算法敏感性90.1%、特异性52.1%,在2岁以下或低年龄别体重儿童中敏感性仍>90%。

要点

  • 临床证据可识别71.4%的结核病例,加入基线胸片后提升至89.3%。
  • 算法总体敏感性90.1%、特异性52.1%,AUC为0.87。
  • 2岁以下或低体重儿童中算法敏感性仍>90%。

核心结论

  • 临床证据本身足以支持多数儿童抗结核治疗决策。
  • 基于证据的算法可能促进 decentralized 快速启动治疗,降低儿童死亡负担。

研究设计与样本

  • 采用回归模型分析基线临床评估对结核诊断的贡献,并加入基线胸片和Xpert MTB/RIF结果构建算法。

主要发现

  • 478名儿童中位年龄16.2个月(IQR 9.8–30.9个月),242名(50.6%)回顾性分类为结核,其中104名(43.0%)细菌学确诊。
  • 最终模型AUC为0.87。
  • 临床证据识别71.4%的结核病例,加入基线胸片结果后比例升至89.3%。
  • 算法敏感性90.1%、特异性52.1%,在<2岁或低年龄别体重儿童中敏感性维持>90%。

临床怎么用

  • 在资源有限地区,可依据临床证据和基线胸片快速启动儿童抗结核治疗。
  • 算法在高敏感性下特异性有限,需结合其他评估避免过度治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limitations in the sensitivity and accessibility of diagnostic tools for childhood tuberculosis contribute to the substantial gap between estimated cases and cases notified to national tuberculosis programs. Thus, tools to make accurate and rapid clinical diagnoses are necessary to initiate antituberculosis treatment in more children. METHODS: We analyzed data from a prospective cohort of children <13 years old being routinely evaluated for pulmonary tuberculosis in Cape Town, South Africa, from March 2012 to November 2017. We developed a regression model to describe the contributions of baseline clinical evaluation to the diagnosis of tuberculosis using standardized, retrospective case definitions. We included baseline chest radiographic and Xpert MTB/RIF assay results to the model to develop an algorithm with ≥90% sensitivity in predicting tuberculosis. RESULTS: Data from 478 children being evaluated for pulmonary tuberculosis were analyzed (median age, 16.2 months; interquartile range, 9.8-30.9 months); 242 (50.6%) were retrospectively classified with tuberculosis, bacteriologically confirmed in 104 (43.0%). The area under the receiver operating characteristic curve for the final model was 0.87. Clinical evidence identified 71.4% of all tuberculosis cases in this cohort, and inclusion of baseline chest radiographic results increased the proportion to 89.3%. The algorithm was 90.1% sensitive and 52.1% specific, and maintained a sensitivity of >90% among children <2 years old or with low weight for age. CONCLUSIONS: Clinical evidence alone was sufficient to make most clinical antituberculosis treatment decisions. The use of evidence-based algorithms may improve decentralized, rapid treatment initiation, reducing the global burden of childhood mortality.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gunasekera KS, Walters E, van der Zalm MM, et al. Development of a Treatment-decision Algorithm for Human Immunodeficiency Virus-uninfected Children Evaluated for Pulmonary Tuberculosis. Clin Infect Dis. 2021. PMID: 33449999. doi:10.1093/cid/ciab018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。